Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities

Vaccine

Volumn 28, Issue 21, 2010, Pages 3635-3641

  Yu, Yongxin ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

Attenuation; Genotype; Japanese encephalitis virus; Phenotype; Stability

Indexed keywords

AMINO ACID; CYCLOPHOSPHAMIDE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; NUCLEOTIDE; SA 14 14 2; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; CRYOPRESERVATION; GENE SEQUENCE; GENETIC STABILITY; GENETIC TRAIT; GENOTYPE; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; LICENSING; MOSQUITO; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; VIRUS ATTENUATION; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SUBSTITUTION; ANIMALS; CRICETINAE; CRYOPRESERVATION; CULICIDAE; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; GENOTYPE; JAPANESE ENCEPHALITIS VACCINES; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MICE; PHENOTYPE; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS;

EID: 77953135441     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.105     Document Type: Review

References (44)

1. Guidelines for the production and control of Japanese encephalitis vaccine (live) for human use. In: WHO Expert Committee On Biological Standardization. Fifth-first report. Geneva: World Health Organization; 2002. (Annex 3 WHO Technical Report Series No. 910).
2. Ma W.X., Yu Y.X., Wang S.G., Zhou B.L., Ma Y.H., Feng S.Y., et al. Observation of safety and serological efficacy from large-scale field trial on Japanese encephalitis live vaccine. Chin J Biol 6 (1993) 188-191
3. Huang Z.L., Li X.G., and Wu J.N. Observation on the side reaction after vaccination with Japanese encephalitis live vaccine. Chin J Zoonoses 14 (1998) 60-61
4. Liu Z.L., Hennessy S., Strom B.L., Tsai T.F., Wan C.M., and Tang S.C. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. J Infect Dis 176 (1997) 1366-1369
5. Zhou B.L., Jia L.L., Xu X.L., Wang H.M., Cai Z.Y., Zhang Z.J., et al. A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas. Chin J Epidemiol 20 (1999) 38-41
6. Sohn Y.M., Park M.S., Rho H.O., Chandler L.J., Shope R.E., and Tsai T.F. Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine 17 (1999) 2259-2264
7. Bista M.B., Banerjee M.K., Shin S.H., Tandan J.B., Kim M.H., and Sohn Y.M. Efficacy of single-dose SA14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 358 9284 (2001) 791-795
8. Yu Y.X., Ao J., Lei W.X., and LI H.M. Studies on the variation of Japanese encephalitis virus: pathogenicity and immunogenicity in mice and monkeys after serial passages in primary hamster kidney cells. Acta Microbiol Sin 8 (1962) 260-269
9. 14-A clone viruses. Acta Microbiol Sin 12 (1966) 41-49
10. Yu Y.X., Ao J., Zhu Y.G., Fong T., Huang N.J., and Liu L.H. Studies on the variation of Japanese encephalitis virus. V. The biological characteristics of an attenuated live vaccine virus strain. Acta Microbiol Sin 13 (1973) 16-24
11. Ao J., Yu Y.X., Wu H.Y., Wu P.F., Wang Z.W., and Zhang G.M. Selection of a better immunogenic and highly attenuated live vaccine virus strain of Japanese encephalitis. II. Safety and immunogenicity of live JE Vaccine SA14-14-2 observed in inoculated children. Chin J Microbiol Immunol 3 (1983) 245-248
12. Yu Y.X., Wu P.F., Ao J., and Liu L.H. Selection of a better immunogenic and highly attenuated live vaccine virus strain of Japanese B encephalitis. I. Some biological characteristics of SA14-14-2 mutant. Chin J Microbiol Immunol 1 (1981) 77-83
13. Eckels K.H., Yu Y.X., Dubois D.R., Marchett N.J., Trent D.W., and Johnson A.J. Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 6 (1988) 513-518
14. Yu Y.X., Ma W.X., Jia L.L., Jiang X.K., Wang H.Q., and Yue G.Z. Clinical and serological studies of Japanese encephalitis live vaccine, SA14-14-2 PDK strain, in humans. Chin J Biol 7 (1994) 52
15. Yu Y.X., and Wang J.F. In vitro characteristics of attenuated Japanese encephalitis viruses. Chin J Virol 2 (1986) 197-201
16. Ling J.P., Zhu Y.G., Du G.Z., Lang S.H., Jia L.L., and Yu Y.X. Comparison of pathogenicity and pathology between wild Japanese encephalitis virus SA14 and attenuated strain SA14-14-2 in Rhesus monkey and mouse models. Prog Microbiol Immunol 28 (2000) 1-4
17. Fan X.L., Yu Y.X., Li D.F., and Yao Z.H. Comparison of nucleotide and deduced amino acid sequences of E protein gene of the wild-type Japanese encephalitis virus strain SA14 and its different attenuated derivatives. Virol Sin 17 (2002) 216-220
18. Zhu Y.G., Li H.M., and Zang X. Pathology of attenuated Japanese encephalitis virus. Chin J Pathol 10 (1966) 113-116
19. Yu Y.X., Wang J.F., Zhuang G.M., and Li H.M. Response of normal and athymic mice to infection by virulent and attenuated Japanese encephalitis viruses. Chin J Virol 1 (1985) 20-39
20. Jia L.L., Zheng Z., and Yu Y.X. Pathogenicity and immunogenicity of attenuated Japanese encephalitis vaccine (SA14-14-2) in immune-inhibited mice. Virol Sin 8 (1993) 20-24
21. Aihara S., Rao C.M., Yu Y.X., Lee T., Watanabe K., Komiya T., et al. Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process. Virus Genes 5 (1991) 95-109
22. Zeng M., Yu Y.X., Dong G.M., Jia L.L., Yao Y.F., and Li D.F. Sequence analysis of the full-length genome of Japanese encephalitis virus vaccine SA14-14-2. Chin J Microbiol Immunol 21 (2001) 535-539
23. Arroyo J., Guirakhoo F., Fenner S., Zhang Z.X., Monath T.P., and Chambers T.J. Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol (2001) 934-942
24. Guirakhoo F., Zhang Z.X., Chambers T.J., Delagrave S., Arroyo J., Barrett A.D.T., et al. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology 257 (1999) 363-372
25. Ni H., Burns N.J., Chang G.-J., Zhang M.J., Wills M.R., Trent D.W., et al. Comparison of nucleotide and deduced amino and sequence of non-coding regions and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. J Gen Virol 75 (1994) 1505-1510
26. Jia L.L., Zheng Z., Guo Y.P., and Yu Y.X. Stability of live-attenuated Japanese encephalitis vaccine strain SA14-14-2. Chin J Biol 5 (1992) 174-176
27. Wang S.G., Yang H.J., Deng Y.Y., Wang F.B., Zheng Q.W., and Yu Y.X. Studies on the production of live-attenuated Japanese encephalitis vaccine SA14-14-2. Chin J Virol 6 (1990) 38-43
28. Wang S.G., Yu Y.X., Zheng Q.W., Zhang D.Q., Jia L.L., and Li Y.H. Study on adaption of attenuated Japanese encephalitis virus strain (SA14-14-2 PHK) to primary fetal dog kidney cell cultures. Chin J Biol 5 (1992) 49-51
29. Wu Y.L., Liu J., Yang H.Q., Zhao N., Mou J.C., Huang Y.X., et al. Genetic property of attenuated Japanese encephalitis virus strain SA14-14-2 after subculture in suckling mouse brain. Chin J Biol 20 (2007) 19-21
30. Fan X.L., Yu Y.X., Li D.F., and Yao Z.H. The stability of E protein gene of the Japanese encephalitis live-attenuated vaccine virus SA14-14-2. Chin J Virol 18 (2002) 39-47
31. Li Y.H., Liu J., Wang W., Niu J.C., Wu Y.L., Liu R., et al. Study of the genetic stability of Japanese encephalitis attenuated virus strain SA14-14-2 after passaging on primary hamster kidney cells. Chin J Biol 16 (2003) 333-335
32. Gao X.J., Zhao Y.J., Liu C.M., Zou Y., Wei Y., Zheng X.G., et al. The stability of E gene of the Japanese encephalitis attenuated virus strain SA14-14-2. Prog Microbiol Immunol 34 (2006) 1-11
33. Xu L.Y., Xu W.Q., Xu F.H., Wang B., and Zhang X.J. Biological and genetic stability of attenuated Japanese encephalitis vaccine virus strain SA14-14-2. Chin J Biol 21 (2008) 833-837
34. Jia L.L., Yu Y.X., Huang Y., Wang Z.W., Yue G.Z., Zheng Z., et al. Stability of phenotype and E Protein gene of primary virus seed and final product of live attenuated Japanese encephalitis vaccine. Chin J Biol 17 (2004) 12-15
35. Zhang Y.Z., Zhang H.L., Yu Y.X., Feng Y., Dong G.M., Yang W.H., et al. Studies on Culex tritaeniorhynchus and Culex pipiens quinquefascitatus infected orally by Japanese encephalitis SA14-14-2 vaccine virus. Chin J Zoonoses 21 (2005) 584-591
36. Zhang Y.Z., Zhang H.L., Yu Y.X., Feng Y., Dong G.M., Yang W.H., et al. Research on Culex tritaeniorhynchus and Culex pipiens quinquefascitatus intrathoracically infected with attenuated Japanese encephalitis virus SA14-14-2 vaccine strain. Chin J Exp Clin Virol 19 (2005) 344-346
37. Feng Y., Zhang H.L., Yu Y.X., Zhang Z.Y., Yang W.H., Dong G.M., et al. Observations on the replication of virus and stability of virulence in Culex tritaeniorhynchus after intrathoracically inoculation with attenuated Japanese encephalitis virus SA14-14-2 vaccine strain. Chin J Zoonoses 23 (2007) 278-281
38. Liu Z.W., Yu Y.X., Zhang H.L., Wang Z.W., Jia L.L., Zhang Z.Y., et al. Biological and molecular characteristics of live attenuated Japanese encephalitis vaccine virus strain SA14-14-2 inoculated intrathoracically to Culex tritaeniorhynchus. Chin J Biol 20 (2007) 419-421
39. Monath T.P. Yellow fever vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), Saunders, USA 667-670
40. Sutter R.W., and Cochi S.L. Live attenuated poliovirus vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), Saunders, USA 667-670
41. Yu Y.X., Zhang G.M., Guo Y.P., Ao J., and Li H.M. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg 39 (1988) 214-217
42. Zhou B.L., Zhang M., Chen P.Q., Jiang X.K., Zhang L.B., Quan B.H., et al. An 11 year follow-up of epidemiological effect of live attenuated Japanese encephalitis vaccine (SA14-14-2). Chin J Biol 14 (2001) 183-185
43. Tandan J.B., Ohrr H., Sohn Y.M., Yoksan S.J., Nam C.M., et al. Single dose of SA14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine 25 (2007) 5041-5045
44. Sohn Y.M., Tandan J.B., Yoksan S., Ji J., and Ohrr H. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses. Vaccine 26 (2008) 1638-1643